Updated NICE Guidance For Alzheimer's Disease Now Recommends The First Transdermal Patch As Well As Oral Capsules
Links shared publicly online about this topic.
- 569total visits
Updated NICE Guidance For Alzheimer's Disease Now Recommends The First Transdermal Patch As Well As Oral Capsules
Novartis Pharmaceuticals UK Ltd. welcomes the update to National Institute for Health and Clinical Excellence (NICE) guidance TA1111 and is pleased that the EXELON Patch (rivastigmine transdermal
View full resource at medicalnewstoday.com
Tags: Alzheimer's Disease, Alzheimer's Disease Medication, Disease and Condition, Pharma, Healthy Living, Exelon, Novartis, disease
Most Recently Shared on January 19, 2011 at 1:05 pm By:
Updated NICE Guidance For Alzheimer's Disease Now Recommends The First Transdermal Patch As Well As Oral Capsules http://mnt.to/3Q69
Advertisement
